COSCIENS Biopharma Inc. (TSX:CSCI)

Market Cap	9.58M -33.9%
Revenue (ttm)	11.17M -10.3%
Net Income	5.66M
EPS	1.79
Shares Out	3.18M
PE Ratio	1.69
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,497
Open	3.180
Previous Close	3.190
Day's Range	3.010 - 3.280
52-Week Range	1.100 - 6.000
Beta	1.93
Analysts	Buy
Price Target	109,074.72 (+3,623,644.85%)
Earnings Date	Aug 12, 2026

About COSCIENS Biopharma

COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, the United Kingdom, and internationally. It operates through Active Ingredient and Pharmaceutical segments. The company offers active ingredients comprising oat beta glucan, a functional ingredient that supports overall health and wellness; oat powder and peptides; oat oil which is extracted from whole oat kernels by a gentle process that retains all the important bi...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1990
• Employees: 28
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: CSCI

Financial Performance

In 2025, COSCIENS Biopharma's revenue was $7.50 million, a decrease of -21.79% compared to the previous year's $9.59 million. Losses were -$10.36 million, -32.34% less than in 2024.

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 19, 2026

Data Sources Report a data error